Trial intelligence / Profile preview

Sublingual Versus Vaginal Misoprostol for Labor Induction at Term

NCT00140114Phase 3Completed

Sponsor
American University of Beirut Medical Center
Start
Jan 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of misoprostol in labor induction (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Proportion of women satisfied with the route of administration of misoprostol at 48 hours. Started Jan 2004; status: completed.

02

Drugs

misoprostol
03

Conditions

labor induction

Beyond the preview

Go deeper on NCT00140114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00140114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call